Atlas Trials

Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation

Clinical trial NCT04209959 · UNKNOWN

Trial details

NCT number
NCT04209959
Sponsor
Second Affiliated Hospital of Nanchang University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2019-01-01
Primary completion
2020-01-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.